IPO previews for the week

With the start of a new week comes the excitement of a new group of companies looking to make a difference through their IPOs. According to Benzinga Pro, these enticing companies are set to go public this week.

• ParaZero Technologies Ltd. PRZO will be publicly traded starting May 12, 2023. The company’s price range is $4.00 to $6.00 with an insider ban of 180 days. ParaZero Technologies Ltd. will be offering 1,950,000 shares at a price of $5.00 per share.
• CaliberCos Inc CWD will be publicly traded starting May 11, 2023. CaliberCos Inc will offer 1,200,000 shares at $5.00 per share with an insider lock-up period of 180 days.
• MDNA Life Sciences Inc MDLS will be publicly traded starting May 10, 2023. The company’s price range is $5.00 to $6.00 with an insider ban of 180 days. MDNA Life Sciences Inc will offer 2,455,000 shares at $5.50 per share.
• Strong Global Entertainment, Inc. SGE will be publicly traded starting May 10, 2023. Strong Global Entertainment, Inc. will be offering 2,000,000 shares at $5.00 per share with an insider lock-up period of 180 days.

Understand IPOs

Initial Public Offerings or IPOs are the transitional processes of private companies that decide to go public and offer shares on exchanges to investors. IPOs typically provide companies with an opportunity to raise capital by circulating shares across the market. A company interested in becoming publicly traded must first meet SEC requirements and work with investment banks through audits to determine pricing, offering date, and other key data points prior to the offering.

Companies and investment banks will work to set a price range within which to sell the stock. This is called the supply area. Once a company goes public, its stock has an opening price. The insider lockup period is typically a set number of days after an IPO, during which company insiders or employees with 10% or more ownership of their company cannot sell stock.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.